News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
261,270 Results
Type
Article (13589)
Company Profile (110)
Press Release (247571)
Section
Business (87949)
Career Advice (461)
Deals (15325)
Drug Delivery (64)
Drug Development (36536)
Employer Resources (49)
FDA (6259)
Job Trends (6184)
News (150035)
Policy (14009)
Tag
Academia (435)
Alliances (23098)
Alzheimer's disease (351)
Approvals (6253)
Artificial intelligence (61)
Bankruptcy (143)
Best Places to Work (4325)
Biotechnology (44)
Breast cancer (42)
Cancer (315)
Career advice (405)
Cell therapy (44)
Clinical research (30405)
Collaboration (155)
Compensation (62)
COVID-19 (747)
C-suite (52)
Data (343)
Diabetes (53)
Diagnostics (1236)
Drug pricing (57)
Earnings (31558)
Employer resources (43)
Events (36739)
Executive appointments (172)
FDA (6439)
Funding (107)
Gene therapy (59)
GLP-1 (292)
Government (1268)
Healthcare (3521)
Infectious disease (765)
Inflammatory bowel disease (46)
Interviews (58)
IPO (5817)
Job creations (2049)
Job search strategy (372)
Layoffs (167)
Legal (3411)
Lung cancer (46)
Manufacturing (99)
Medical device (1261)
Medtech (1263)
Mergers & acquisitions (9544)
Metabolic disorders (168)
Neuroscience (449)
NextGen Class of 2024 (1580)
Non-profit (590)
Northern California (434)
Obesity (101)
Opinion (109)
Patents (52)
People (28458)
Pharmaceutical (64)
Phase I (7907)
Phase II (12859)
Phase III (11552)
Pipeline (183)
Policy (45)
Postmarket research (1399)
Preclinical (3166)
Radiopharmaceuticals (116)
Rare diseases (90)
Real estate (2629)
Regulatory (9821)
Research institute (562)
Resumes & cover letters (55)
Southern California (435)
Startups (1625)
United States (4275)
Vaccines (112)
Weight loss (78)
Date
Today (44)
Last 7 days (287)
Last 30 days (1264)
Last 365 days (12709)
2024 (11612)
2023 (14248)
2022 (19557)
2021 (20069)
2020 (19033)
2019 (14888)
2018 (11713)
2017 (13888)
2016 (13130)
2015 (15474)
2014 (12419)
2013 (10595)
2012 (11395)
2011 (11925)
2010 (10888)
Location
Africa (312)
Arizona (42)
Asia (19793)
Australia (2560)
California (1006)
Canada (600)
China (111)
Colorado (41)
Connecticut (42)
Europe (38785)
Florida (152)
Illinois (111)
Indiana (86)
Japan (43)
Kansas (51)
Maryland (155)
Massachusetts (881)
Minnesota (56)
New Jersey (422)
New York (279)
North Carolina (278)
Northern California (434)
Pennsylvania (286)
South America (498)
Southern California (435)
Texas (138)
Virginia (41)
Washington State (70)
261,270 Results for "adamis pharmaceuticals".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Policy
Adamis Pharmaceuticals Changes Name to DMK Pharmaceuticals to Reflect New Strategic Focus
Adamis Pharmaceuticals Corporation announced the company changed its name to DMK Pharmaceuticals Corporation in order to better reflect its new strategic focus on advancing small molecules for the treatment of substance use disorders.
September 7, 2023
·
6 min read
Deals
Adamis Pharmaceuticals Announces Closing of the Merger with DMK Pharmaceuticals
Adamis Pharmaceuticals Corporation, a commercial-stage biopharmaceutical company, announced the closing of its merger with DMK Pharmaceuticals Corporation.
May 25, 2023
·
7 min read
Deals
Adamis Pharmaceuticals Announces Pricing of $8.0 Million Public Offering
Adamis Pharmaceuticals Corporation today announced the pricing of its public offering of 5,930,000 units at a public offering price of $1.35 per unit.
August 2, 2023
·
5 min read
Biotech Beach
Adamis Pharmaceuticals Participated in White House Meeting Regarding Opioid Overdose Prevention
Adamis Pharmaceuticals Corporation today announced that Eboo Versi, MD, PhD, CEO of Adamis Pharmaceuticals is proud and excited to have participated in the White House Roundtable with Opioid Reversal Product Manufacturers, hosted by White House Office of National Drug Control Policy Director, Dr. Rahul Gupta.
June 22, 2023
·
7 min read
Business
Adamis Pharmaceuticals to Fund ZIMHI® Clinical Study with University of Leiden Opioid Expert
Adamis Pharmaceuticals Corporation today announced the Company has committed to fund an unrestricted research grant to the Leiden University Medical Center (LUMC) Anesthesia and Pain Research Unit.
July 28, 2023
·
6 min read
Business
Adamis Pharmaceuticals Reports Second Quarter 2023 Financial Results and Provides Corporate Update
Adamis Pharmaceuticals Corporation (NASDAQ: ADMP), a commercial-stage biopharmaceutical company, today announced financial results for the second quarter ended June 30, 2023, and provided an update on recent corporate developments.
August 21, 2023
·
10 min read
Biotech Beach
Adamis Pharmaceuticals Announces Closing of $8.0 Million Public Offering
Adamis Pharmaceuticals Corporation, a commercial-stage biopharmaceutical company, announced the closing of its public offering of 5,930,000 units, with each unit consisting of one share of common stock and one warrant to purchase one share of common stock.
August 4, 2023
·
5 min read
Deals
Adamis Pharmaceuticals and DMK Pharmaceuticals Announce Agreement and Plan of Merger
Adamis Pharmaceuticals Corporation (NASDAQ: ADMP) and DMK Pharmaceuticals, Corp. today announced that the companies have entered into an Agreement and Plan of Merger and Reorganization (the “Agreement”).
February 27, 2023
·
12 min read
Business
Adamis Pharmaceuticals Reports First Quarter 2023 Financial Results and Provides Corporate Update
Adamis Pharmaceuticals Corporation announced financial results for the first quarter ended March 31, 2023, and provided an update on recent corporate developments.
May 15, 2023
·
10 min read
Biotech Beach
Adamis Pharmaceuticals Announces Reverse Stock Split - May 19, 2023
Adamis Pharmaceuticals Corporation, a commercial-stage biopharmaceutical company, announced that it will effect a 1-for-70 reverse stock split of its common stock that will become effective on May 22, 2023, at 12:01 a.m., Eastern Time.
May 19, 2023
·
6 min read
1 of 26,127
Next
